Opus Genetics (Nasdaq: IRD) is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and other treatments for ophthalmic disorders. This company webcast was recorded during the Lytham...

read more